HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Susanne Fuessel Selected Research
Susanne Fuessel Research Topics
Disease
47
Neoplasms (Cancer)
03/2024 - 07/2003
32
Prostatic Neoplasms (Prostate Cancer)
12/2022 - 07/2003
25
Urinary Bladder Neoplasms (Bladder Cancer)
05/2020 - 09/2003
11
Renal Cell Carcinoma (Grawitz Tumor)
09/2023 - 07/2008
7
Carcinoma (Carcinomatosis)
03/2024 - 06/2004
5
Neoplasm Metastasis (Metastasis)
01/2022 - 07/2009
4
Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
09/2021 - 06/2012
2
Carcinogenesis
02/2014 - 09/2003
2
Inflammation (Inflammations)
12/2013 - 06/2012
2
Breast Neoplasms (Breast Cancer)
09/2008 - 11/2005
2
Transitional Cell Carcinoma
12/2004 - 11/2004
1
Adenocarcinoma
01/2020
1
Non-Muscle Invasive Bladder Neoplasms
11/2017
1
Disease Progression
11/2016
1
Multiple Myeloma
09/2014
Drug/Important Bio-Agent (IBA)
13
Proteins (Proteins, Gene)
FDA Link
11/2016 - 09/2004
11
Biomarkers (Surrogate Marker)
IBA
03/2024 - 06/2012
11
Survivin
IBA
02/2016 - 06/2004
9
Messenger RNA (mRNA)
IBA
01/2014 - 07/2003
7
Small Interfering RNA (siRNA)
IBA
09/2015 - 10/2004
6
DNA (Deoxyribonucleic Acid)
IBA
03/2024 - 06/2004
6
Cisplatin (Platino)
FDA Link
Generic
06/2022 - 11/2004
6
MicroRNAs (MicroRNA)
IBA
08/2020 - 02/2014
6
Oligodeoxyribonucleotides
IBA
05/2008 - 09/2003
5
Telomerase (Telomerase Reverse Transcriptase)
IBA
05/2008 - 09/2003
4
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
04/2022 - 09/2008
4
Carbon Nanotubes (Carbon Nanotube)
IBA
01/2017 - 03/2014
4
Mitomycin (Mitomycin-C)
FDA Link
Generic
01/2017 - 11/2004
3
Cell-Free Nucleic Acids
IBA
03/2024 - 02/2019
3
Prostate-Specific Antigen (Semenogelase)
IBA
03/2024 - 06/2006
3
Docetaxel (Taxotere)
FDA Link
12/2022 - 01/2017
3
Platinum
IBA
06/2022 - 03/2014
3
Neuropilin-2
IBA
01/2022 - 01/2019
3
Catenins
IBA
11/2017 - 04/2015
3
Carbon
IBA
01/2017 - 03/2014
3
Antigens
IBA
12/2013 - 06/2006
2
C-Reactive Protein
IBA
09/2023 - 06/2012
2
enzalutamide
IBA
01/2022 - 01/2020
2
Tumor Biomarkers (Tumor Markers)
IBA
08/2020 - 07/2003
2
Androgens
IBA
01/2020 - 09/2005
2
RNA (Ribonucleic Acid)
IBA
01/2020 - 09/2008
2
Transcription Factors (Transcription Factor)
IBA
11/2017 - 11/2015
2
Keratin-20 (Cytokeratin 20)
IBA
09/2017 - 02/2016
2
Tyrosine Kinase Inhibitors
IBA
06/2016 - 01/2013
2
Sunitinib (Sutent)
FDA Link
06/2016 - 01/2013
2
Aldehyde Dehydrogenase
IBA
11/2015 - 04/2015
2
Complementary DNA (cDNA)
IBA
03/2015 - 09/2004
2
Plasminogen Activator Inhibitor 1
IBA
12/2014 - 06/2013
2
Carboplatin (JM8)
FDA Link
Generic
10/2014 - 03/2014
2
Enzymes
IBA
06/2012 - 12/2004
2
Peptide Hydrolases (Proteases)
FDA Link
04/2010 - 11/2005
2
Keratin-8 (Keratin 8)
IBA
08/2009 - 12/2004
2
Keratins (Keratin)
IBA
08/2009 - 12/2004
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
05/2008 - 07/2005
2
Nucleic Acids
IBA
02/2007 - 01/2007
2
prostein
IBA
10/2006 - 06/2006
2
Hormones (Hormone)
IBA
06/2006 - 06/2004
2
G-Protein-Coupled Receptors (Receptors, G Protein Coupled)
IBA
05/2006 - 09/2004
2
Gemcitabine
FDA Link
07/2005 - 11/2004
1
cyclopropapyrroloindole
IBA
09/2023
1
Immune Checkpoint Inhibitors
IBA
09/2023
1
Androgen Receptors (Androgen Receptor)
IBA
01/2022
1
Neuropilins
IBA
01/2020
1
Mechanistic Target of Rapamycin Complex 2
IBA
01/2020
1
Indicators and Reagents (Reagents)
IBA
01/2019
1
Wnt Receptors
IBA
06/2018
1
ErbB Receptors (EGF Receptor)
IBA
11/2017
1
Luciferases
IBA
11/2017
1
Lysine (L-Lysine)
FDA Link
11/2017
1
Trypsin
IBA
11/2017
1
alpha-methylacyl-CoA racemase
IBA
11/2017
1
Insulin-Like Peptides
IBA
09/2017
1
Enhancer of Zeste Homolog 2 Protein
IBA
11/2016
1
Midkine
IBA
11/2016
1
Catechin (Z 7300)
IBA
11/2015
1
Tea
IBA
11/2015
1
Galectin 3 (LGALS3)
IBA
01/2015
1
prostatic acid phosphatase
IBA
01/2015
1
Vinculin
IBA
01/2015
1
Tissue Extracts
IBA
12/2014
1
Phosphotransferases (Kinase)
IBA
01/2014
1
Agglutinins
IBA
01/2014
1
Tyrosine (L-Tyrosine)
FDA Link
01/2014
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
01/2014
1
EphA1 Receptor (Eph Receptor)
IBA
01/2014
1
EphA2 Receptor
IBA
01/2014
1
Ephrins
IBA
01/2014
1
Ephrin-A1 (Ephrin A1)
IBA
01/2014
1
Ligands
IBA
01/2014
Therapy/Procedure
20
Therapeutics
09/2023 - 06/2004
7
Drug Therapy (Chemotherapy)
06/2022 - 06/2004
3
Castration
06/2022 - 01/2020
2
Radiotherapy
11/2015 - 04/2015
2
Nephrectomy
12/2014 - 07/2009
2
Prostatectomy (Retropubic Prostatectomy)
02/2014 - 10/2006
2
Immunotherapy
06/2006 - 09/2004
1
Treatment Delay
03/2019
1
Precision Medicine
11/2017
1
Catheters
11/2017
1
Chemoradiotherapy
11/2015